Lauren Ostermann

12PUBLICATIONS
37CO-AUTHORS
Gene and molecular therapyHaematological tumoursMedical infection agents (incl. prions)Molecular targetsMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 13, 2026
The novel hypomethylating agent NTX-301 reprograms epigenetic and Hippo signaling pathways and exhibits pre-clinical activity in venetoclax-resistant and TP53-mutant AML.

|Jul 03, 2025
Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemia.

Bing Z Carter, Po Yee Mak, Edward Ayoub

|Mar 08, 2024
Correction: Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia.

Hiroki Akiyama, Ran Zhao, Lauren B Ostermann

|Dec 26, 2023
Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia.

Hiroki Akiyama, Ran Zhao, Lauren B Ostermann

|Nov 29, 2023
Enhanced TP53 reactivation disrupts MYC transcriptional program and overcomes venetoclax resistance in acute myeloid leukemias.

Yuki Nishida, Jo Ishizawa, Edward Ayoub

|Jun 23, 2023
Mdm2/p53 levels in bone marrow mesenchymal stromal cells are essential for maintaining the hematopoietic niche in response to DNA damage.

Rasoul Pourebrahim, Rafael Heinz Montoya, Zoe Alaniz

Pageof 2

Frequent Collaborators

12 joint publications

Michael Andreeff

8 joint publications

Bing Z Carter

6 joint publications

Steffen Boettcher

5 joint publications

Edward Ayoub